USA - NYSE:MPLN - US62548M2098 - Common Stock
The current stock price of MPLN is 23.15 USD. In the past month the price increased by 40.13%. In the past year, price decreased by -47.86%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| VEEV | VEEVA SYSTEMS INC-CLASS A | 39.43 | 48.15B | ||
| DOCS | DOXIMITY INC-CLASS A | 42.65 | 11.90B | ||
| WAY | WAYSTAR HOLDING CORP | 26.79 | 6.85B | ||
| HTFL | HEARTFLOW INC | N/A | 2.94B | ||
| CERT | CERTARA INC | 23.17 | 1.82B | ||
| SDGR | SCHRODINGER INC | N/A | 1.36B | ||
| TDOC | TELADOC HEALTH INC | N/A | 1.36B | ||
| PHR | PHREESIA INC | N/A | 1.34B | ||
| GDRX | GOODRX HOLDINGS INC-CLASS A | 9.3 | 1.13B | ||
| LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 1.08B | ||
| CTEV | CLARITEV CORP | N/A | 1.05B | ||
| CCLDO | CARECLOUD INC - CCLD 8 3/4 PERP | N/A | 898.45M |
Multiplan Corp is a US-based company operating in Health Care Technology industry. The company is headquartered in New York City, New York and currently employs 2,800 full-time employees. The company went IPO on 2020-02-10. MultiPlan Corporation is a provider of data analytics and technology-enabled end-to-end cost management, as well as payment and revenue integrity solutions to the United States healthcare industry. The firm interprets customer’s needs and customizes solutions that combine its payment and revenue integrity, network-based, analytics-based, and data and decision science services. Through its data and technology platform, the Company provides out-of-network cost management, payment and revenue integrity, data and decision science, business-to-business (B2B) healthcare payments and other services to the payors of healthcare, which are primarily health insurers and their administrative-services-only (ASO) platforms, self-insured employers, federal and state government-sponsored health plans and other health plan sponsors, and, indirectly, the plan members who are the consumers of healthcare services. The firm is a partner to over 700 healthcare payors, brokers, and others.
MULTIPLAN CORP
115 Fifth Avenue
New York City NEW YORK 10019 US
CEO: Mark H. Tabak
Employees: 2800
Phone: 12127802000
Multiplan Corp is a US-based company operating in Health Care Technology industry. The company is headquartered in New York City, New York and currently employs 2,800 full-time employees. The company went IPO on 2020-02-10. MultiPlan Corporation is a provider of data analytics and technology-enabled end-to-end cost management, as well as payment and revenue integrity solutions to the United States healthcare industry. The firm interprets customer’s needs and customizes solutions that combine its payment and revenue integrity, network-based, analytics-based, and data and decision science services. Through its data and technology platform, the Company provides out-of-network cost management, payment and revenue integrity, data and decision science, business-to-business (B2B) healthcare payments and other services to the payors of healthcare, which are primarily health insurers and their administrative-services-only (ASO) platforms, self-insured employers, federal and state government-sponsored health plans and other health plan sponsors, and, indirectly, the plan members who are the consumers of healthcare services. The firm is a partner to over 700 healthcare payors, brokers, and others.
The current stock price of MPLN is 23.15 USD. The price decreased by -1.53% in the last trading session.
MPLN does not pay a dividend.
MPLN has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
MULTIPLAN CORP (MPLN) has a market capitalization of 375.03M USD. This makes MPLN a Small Cap stock.
You can find the ownership structure of MULTIPLAN CORP (MPLN) on the Ownership tab.
ChartMill assigns a technical rating of 7 / 10 to MPLN. When comparing the yearly performance of all stocks, MPLN is one of the better performing stocks in the market, outperforming 97.53% of all stocks.
ChartMill assigns a fundamental rating of 2 / 10 to MPLN. Both the profitability and financial health of MPLN have multiple concerns.
Over the last trailing twelve months MPLN reported a non-GAAP Earnings per Share(EPS) of -69.59. The EPS decreased by -1059.83% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -31.95% | ||
| ROE | -1958.81% | ||
| Debt/Equity | 53.67 |
9 analysts have analysed MPLN and the average price target is 13.94 USD. This implies a price decrease of -39.78% is expected in the next year compared to the current price of 23.15.
For the next year, analysts expect an EPS growth of 87.02% and a revenue growth 0.75% for MPLN